Skip to content

Microdosing research published in 2020

Page 2 of 2: studies 21 to 21 of 21, newest first. Back to the microdosing overview

Studies

The therapeutic potential of microdosing psychedelics in depression

Therapeutic Advances in Psychopharmacology 2020 Kim P. C. Kuypers 83 citations

Microdosing psychedelics is the repeated use of small doses of, for example, lysergic acid diethylamide (LSD) and psilocybin, typically for a few weeks. Despite the popular and scientific attention in recent years, and claims by users that it has therapeutic value in affective disorders like depression, little scientific knowledge is available to back this. The purpose of this review was to...

DOI: 10.1177/2045125320950567 (opens in new tab) Depression economics Pharmacology